WAKIX Demonstrated Efficacy and Safety in Clinical Studies

Significant reduction in excessive daytime sleepiness (EDS) and significantly fewer cataplexy attacks compared with placebo

Learn more about the clinical study results for WAKIX in both EDS and cataplexy in narcolepsy, and view the WAKIX safety profile from clinical studies.